IsentioRipSeq offers a cutting-edge sequence-based analysis platform designed to significantly expedite the identification of infectious pathogens in both pure and poly-microbial samples. By leveraging novel algorithms, Ripseq can reduce the time required for analysis to under five minutes, achieving up to a 90% reduction in identification time compared to traditional methods. The platform is agnostic to sequencing technology, allowing users to utilize any sequencing method, including Next Generation Sequencing (NGS) and Sanger sequencing. This flexibility is complemented by the Ripseq DB, a curated database that enhances the accuracy of pathogen identification by filtering out uninformative references, ensuring that users receive reliable results.

The Ripseq system operates as a cloud-based Software as a Service (SaaS) solution, which means it is always accessible and continuously updated with the latest algorithms and database references. Users can upload their sequencing files with a significant reduction in data size, minimizing the need for extensive file storage and lengthy uploads. The platform's bulk analysis capabilities allow for efficient processing of both mono and polymicrobial samples, automatically generating reports and confidence status flags. Overall, IsentioRipSeq provides a comprehensive and efficient diagnostic solution that enhances the speed and accuracy of pathogen identification in clinical settings.

Norway

Pathogenomix Ripseq sequence-based analysis reduces the time needed to identify infectious pathogens, in pure- or poly-microbial samples, by up to 90% - and provides answers where other methods fail. Use any sequencing technology you want - Sanger or NGS - Ripseq is platform agnostic.

Combined with Ripseq DB, this is complete SaaS diagnostic solution, able to identify pathogens more accurately, faster and at lower cost than current methods.

IsentioRipSeq

Company Details